biotech / news / / The Economic Times
India faces challenges with essential drug ingredient supplies.
India has reduced customs duties on about 40 petrochemical products from April 1 to ease supplies.
KEY POINTS
- Methanol supply has become a significant concern, with discussions ongoing to boost domestic production.
- The government has suspended quality control requirements for morpholine to address supply bottlenecks.
- Despite supply disruptions, no significant drug price increases or major shortages have occurred so far.
- Propylene supply for drug manufacturing is being maintained by Bharat Petroleum's Kochi and Mumbai refineries.
COMPANIES
Summarized by Newsio from The Economic Times. How we summarize →